Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA reports on ongoing safety review of somatropin

Dec. 28, 2010

Degludec improves long-term glycemic control in phase IIIa diabetes trials

Dec. 28, 2010

Leo Pharma claims new positive modulators of calcium-sensing CaS receptor

Dec. 28, 2010

Pfizer identifies new GPR119 agonists

Dec. 28, 2010

GO-CoA-Tat controls glucose and weight in preclinical study

Dec. 28, 2010

Oramed receives grant to support its diabetes research

Dec. 27, 2010

Arena and Eisai attend end-of-review meeting with FDA for lorcaserin

Dec. 27, 2010

Corcept presents phase III data for Corlux for Cushing's syndrome

Dec. 27, 2010

Amylin and Lilly submit NDA for Byetta as an add-on therapy to basal insulin

Dec. 24, 2010

Living Cell Technologies adds patients to Diabecell trial in New Zealand

Dec. 24, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...